The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Niesen, F. H., Berglund, H., & Vedadi, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.321 · Cited by 2,408
What is principal component analysis?
Ringnér, M. (2008) · Nature Biotechnology · doi:10.1038/nbt0308-303 · Cited by 2,407
Audeh, M. W., Carmichael, J., Penson, R. T., Friedlander, M., Powell, B., Bell-McGuinn, K. M., Scott, C., Weitzel, J. N., Oaknin, A., Loman, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60893-8 · Cited by 2,279
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Tutt, A., Robson, M., Garber, J. E., Domchek, S. M., Audeh, M. W., Weitzel, J. N., Friedlander, M., Arun, B., Loman, N., Schmutzler, R. K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60892-6 · Cited by 1,655
Amé, J., Spenlehauer, C., & de Murcia, G. (2004) · BioEssays · doi:10.1002/bies.20085 · Cited by 1,459
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
Jagtap, P., & Szabó, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1718 · Cited by 896
Toward a unified nomenclature for mammalian ADP-ribosyltransferases
Hottiger, M. O., Hassa, P. O., Lüscher, B., Schüler, H., & Koch-Nolte, F. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.12.003 · Cited by 811
Self-citationVedadi, M., Niesen, F. H., Allali-Hassani, A., Fedorov, O. Y., Finerty, P. J., Wasney, G. A., Yeung, R., Arrowsmith, C., Ball, L. J., Berglund, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605224103 · Cited by 589
Self-citationHassa, P. (2008) · Frontiers in Bioscience · doi:10.2741/2909 · Cited by 584
Novel inhibitors of poly(ADP-ribose) synthetase
Purnell, M. R., & Whish, W. J. (1980) · Biochemical Journal · doi:10.1042/bj1850775 · Cited by 527
Calabrese, C. R., Almassy, R., Barton, S., Batey, M. A., Calvert, A. H., Canan-Koch, S., Durkacz, B. W., Hostomsky, Z., Kumpf, R. A., Kyle, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh005 · Cited by 487
Edwards, A. M., Isserlin, R., Bader, G. D., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · Nature · doi:10.1038/470163a · Cited by 411
Frye, S. V. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.296 · Cited by 375
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
Fedorov, O., Marsden, B., Pogacic, V., Rellos, P., Müller, S., Bullock, A. N., Schwaller, J., Sundström, M., & Knapp, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708800104 · Cited by 359
Substrate-Assisted Catalysis by PARP10 Limits Its Activity to Mono-ADP-Ribosylation
Kleine, H., Poreba, E., Lesniewicz, K., Hassa, P. O., Hottiger, M. O., Litchfield, D. W., Shilton, B. H., & Lüscher, B. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.009 · Cited by 338
In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs)
Otto, H., Reche, P. A., Bazan, F., Dittmar, K., Haag, F., & Koch-Nolte, F. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-139 · Cited by 259
Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.
Ruf, A., Mennissier de Murcia, J., de Murcia, G., & Schulz, G. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7481 · Cited by 241
The human genome and drug discovery after a decade. Roads (still) not taken
Isserlin, R., Bader, G. D., Edwards, A. M., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1102.0448 · Cited by 232
Signaling Mechanism of Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Inflammatory Diseases
Ba, X., & Garg, N. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.12.004 · Cited by 211
Crystal Structure of Diphtheria Toxin Bound to Nicotinamide Adenine Dinucleotide
Bell, C. E., & Eisenberg, D. (1996) · Biochemistry · doi:10.1021/bi9520848 · Cited by 198
Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
Bell, C. E., & Eisenberg, D. (1996) · Biochemistry · doi:10.1007/978-1-4419-8632-0_4 · Cited by 165
Toward specific functions of poly(ADP-ribose) polymerase-2
Yélamos, J., Schreiber, V., & Dantzer, F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.003 · Cited by 165
Yu, M., Schreek, S., Cerni, C., Schamberger, C., Lesniewicz, K., Poreba, E., Vervoorts, J., Walsemann, G., Grötzinger, J., Kremmer, E., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208410 · Cited by 159
The role of poly(ADP-ribose) polymerase-1 in CNS disease
Kauppinen, T. M., & Swanson, R. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.034 · Cited by 151
Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes
Citarelli, M., Teotia, S., & Lamb, R. S. (2010) · BMC Evolutionary Biology · doi:10.1186/1471-2148-10-308 · Cited by 147
Polymerization of the adenosine 5′-diphosphate ribose moiety of NAD by rat liver nuclear enzyme
Sügimura, T., Fujimura, S., Hasegawa, S., & Kawamura, Y. (1967) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(67)90507-2 · Cited by 120
Structural Basis for the Interaction between Tankyrase-2 and a Potent Wnt-Signaling Inhibitor
Karlberg, T., Markova, N., Johansson, I., Hammarström, M., Schutz, P., Weigelt, J., & Schuler, H. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100249w · Cited by 117
Self-citationDrug Resistance Caused by Reversion Mutation
Ashworth, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2287 · Cited by 112
Structural Basis for Inhibitor Specificity in Human Poly(ADP-ribose) Polymerase-3
Lehtiö, L., Jemth, A., Collins, R., Loseva, O., Johansson, A., Markova, N., Hammarström, M., Flores, A., Holmberg-Schiavone, L., Weigelt, J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900052j · Cited by 100
Self-citationPerspective on the Pipeline of Drugs Being Developed with Modulation of DNA Damage as a Target
Plummer, R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0984 · Cited by 91
Crystal Structure of the Catalytic Domain of Human PARP2 in Complex with PARP Inhibitor ABT-888
Karlberg, T., Hammarström, M., Schutz, P., Svensson, L., & Schuler, H. (2010) · Biochemistry · doi:10.1021/bi902079y · Cited by 88
Self-citationIwashita, A., Hattori, K., Yamamoto, H., Ishida, J., Kido, Y., Kamijo, K., Murano, K., Miyake, H., Kinoshita, T., Warizaya, M., et al. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.036 · Cited by 81
Chiarugi, A., Meli, E., Calvani, M., Picca, R., Baronti, R., Camaioni, E., Costantino, G., Marinozzi, M., Pellegrini-Giampietro, D. E., Pellicciari, R., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.048934 · Cited by 69
Self-citationPoly(ADP-Ribose) Metabolism in Brain and Its Role in Ischemia Pathology
Strosznajder, R. P., Czubowicz, K., Jęśko, H. M., & Strosznajder, J. B. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8124-6 · Cited by 66
Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer
McCabe, N., Cerone, M. A., Ohishi, T., Seimiya, H., Lord, C. J., & Ashworth, A. (2009) · Oncogene · doi:10.1038/onc.2008.483 · Cited by 65
Zinc Binding Catalytic Domain of Human Tankyrase 1
Lehtiö, L., Collins, R., van den Berg, S., Johansson, A., Dahlgren, L. G., Hammarström, M., Helleday, T., Holmberg-Schiavone, L., Karlberg, T., & Weigelt, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.058 · Cited by 62
Self-citationCDK-dependent Activation of Poly(ADP-ribose) Polymerase Member 10 (PARP10)
Chou, H., Chou, H. T., & Lee, S.-C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506745200 · Cited by 55
Carden, C. P., Yap, T. A., & Kaye, S. B. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32833b5126 · Cited by 43
Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
Papeo, G., Forte, B., Orsini, P., Perrera, C., Posteri, H., Scolaro, A., & Montagnoli, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903215883 · Cited by 38
Cited by
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Murai, J., Huang, S.-Y. N., Das, B. B., Renaud, A., Zhang, Y., Doroshow, J. H., Ji, J., Takeda, S., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2753 · Cited by 2,192
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Gibson, B. A., & Kraus, W. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3376 · Cited by 1,226
HemI: A Toolkit for Illustrating Heatmaps
Deng, W., Wang, Y., Liu, Z., Cheng, H., & Xue, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111988 · Cited by 991
Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
Murai, J., Huang, S.-Y. N., Renaud, A., Zhang, Y., Ji, J., Takeda, S., Morris, J., Teicher, B., Doroshow, J. H., & Pommier, Y. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0803 · Cited by 756
Metadata
- Authors
- Wahlberg, E., Karlberg, T., Kouznetsova, E., Markova, N., Macchiarulo, A., Thorsell, A.-G., Pol, E., Frostell, Å., Ekblad, T., Öncü, D., Kull, B., Robertson, G. M., Pellicciari, R., Schüler, H., & Weigelt, J.
- Venue
- Nature Biotechnology
- Published
- 2012-02-19
- Volume
- 30
- Issue
- 3
- Pages
- 283-288
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2085215116
- Cited by
- 457
- References
- 44
- FWCI
- 22.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.